CURE Pharmaceutical Announces the Appointment of New Board Member
OXNARD, Calif., Aug. 02, 2022 (GLOBE NEWSWIRE) -- CURE Pharmaceutical Holding Corp. (OTC: CURR) (CURE), a proprietary platform technology company, today announced the appointment of Gerald Bagg to its board of directors.
- OXNARD, Calif., Aug. 02, 2022 (GLOBE NEWSWIRE) -- CURE Pharmaceutical Holding Corp. (OTC: CURR) (CURE), a proprietary platform technology company, today announced the appointment of Gerald Bagg to its board of directors.
- This strategic addition adds depth in CPG and advertising and brings the number of board members to five.
- A 45+ year veteran of the advertising industry, Gerald is best known for pioneering the BRAND RESPONSE advertising approach to campaigns.
- CURE has partnerships in the United States, China, Mexico, Canada, Israel, and other markets in Europe.